Dr. Sameera Tallapureddy , MD
Internal Medicine • Allen, TX
931 State Highway 121 Apt 2100
Allen, TX 750131182
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Sameera Tallapureddy is listed in NPPES under Internal Medicine.
-
NPI assigned on March 4, 2008; this date does not establish years in practice.
-
Published CMS data list 1,394 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 245 service units.
- 95251 — Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report: 179 service units.
- 99213 — Established patient outpatient office visit: 153 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 22 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,561 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Mounjaro (Tirzepatide) — 170 prescription fills, including refills.
- Ozempic (Semaglutide) — 163 prescription fills, including refills.
- Levothyroxine Sodium — 116 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 43 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 75% of clinicians listed under Internal Medicine in Allen, TX (2024, 25 clinicians with data). Median for this group: 741. Middle half: 357 to 1,394.
More Medicare Part B services than 75% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: 644. Middle half: 277 to 1,324.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 816 in 2020 to 1,394 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
931 State Highway 121 Apt 2100
Allen, TX 750131182
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Premier Independent Physicians Group Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
2002
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
293 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $93,390 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $72,722 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,480 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,005,937 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $51,397.18 across 252 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $31,150.00 across 31 records.
- Compensation for serving as faculty or as a speaker for a medical education program: $13,405.00 across 5 records.
- Food and Beverage: $4,139.46 across 188 records.
Reporting-company totals (3 largest of 30)
- Eli Lilly and Company: $32,922.58 across 82 records.
- Dexcom, Inc.: $15,484.41 across 20 records.
- Amgen Inc.: $543.84 across 21 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
24 years (graduated 2002)
CMS Doctors and Clinicians data list 2002 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2008
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Tallapureddy has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Tallapureddy as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Allen and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 75% of clinicians listed under Internal Medicine in Allen, TX (2024, 25 clinicians with data). Median for this group: 741. Middle half: 357 to 1,394.
More Medicare Part B services than 75% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: 644. Middle half: 277 to 1,324.
Medicare-allowed amount
Close to the middle for clinicians listed under Internal Medicine in Allen, TX (2024, 25 clinicians with data). Median for this group: $65,301. Middle half: $42,204 to $122,155.
A higher Medicare-allowed amount than 65% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: $61,173. Middle half: $27,477 to $116,014.
Paid by Medicare
Close to the middle for clinicians listed under Internal Medicine in Allen, TX (2024, 25 clinicians with data). Median for this group: $51,505. Middle half: $32,894 to $94,411.
A higher Medicare payment amount than 65% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: $47,441. Middle half: $20,511 to $90,151.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Internal Medicine in Allen, TX (2024, 22 clinicians with data). Median for this group: 286. Middle half: 88 to 1,690.
Close to the middle for clinicians listed under Internal Medicine in Texas (2024, 5,692 clinicians with data). Median for this group: 815. Middle half: 119 to 4,814.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine in Allen, TX (2024, 22 clinicians with data). Median for this group: $12,955. Middle half: $537 to $455,775.
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine in Texas (2024, 5,692 clinicians with data). Median for this group: $62,823. Middle half: $3,924 to $436,115.
34 active clinicians are listed under Internal Medicine with a practice address in Allen, TX (9,244 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Allen
17.6% of these 34 clinicians have the CMS telehealth indicator.
73.5% of these 34 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 71% from 816 in 2020 to 1,394 in 2024.
- 2020: 816
- 2021: 866
- 2022: 649
- 2023: 413
- 2024: 1,394
-
Medicare-allowed amount
Medicare-allowed amount increased 31% from $71,343 in 2020 to $93,390 in 2024.
- 2020: $71,343
- 2021: $83,374
- 2022: $63,586
- 2023: $37,452
- 2024: $93,390
-
Paid by Medicare
Paid by Medicare increased 40% from $52,110 in 2020 to $72,722 in 2024.
- 2020: $52,110
- 2021: $61,631
- 2022: $44,173
- 2023: $28,015
- 2024: $72,722
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 28% from 2,165 in 2020 to 1,561 in 2024.
- 2020: 2,165
- 2021: 2,415
- 2022: 2,278
- 2023: 1,298
- 2024: 1,561
-
30-day fills
30-day fills decreased 27% from 4,771 in 2020 to 3,480 in 2024.
- 2020: 4,771
- 2021: 5,631
- 2022: 5,491
- 2023: 3,057
- 2024: 3,480
-
Part D drug cost
Part D drug cost increased 18% from $851,365 in 2020 to $1,005,937 in 2024.
- 2020: $851,365
- 2021: $1,213,694
- 2022: $1,238,511
- 2023: $1,008,557
- 2024: $1,005,937
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 2283% from $2,156.45 in 2021 to $51,397.18 in 2025.
- 2021: $2,156.45
- 2022: $1,918.13
- 2023: $46,787.89
- 2024: $32,681.62
- 2025: $51,397.18
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 252 records totaling $51,397.18.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Dexcom, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
DEXCOM G7 GSS (161) | General | $3,830.00 |
| Dexcom, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
DEXCOM G7 GSS (161) | General | $3,064.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $2,800.00 |
| Dexcom, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
DEXCOM G7 GSS (161) | General | $2,298.00 |
| Dexcom, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
DEXCOM G7 GSS (161) | General | $2,298.00 |
| Dexcom, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
DEXCOM G7 GSS (161) | General | $1,915.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $1,400.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $700.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $700.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $700.00 |
| Eli Lilly and Company |
Travel and Lodging
In-kind items and services
|
— | General | $608.96 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MOUNJARO | General | $525.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
245 | 147 | $264.97 | $121.04 |
|
95251
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report
|
179 | 85 | $90.00 | $32.90 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
153 | 111 | $186.12 | $85.92 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
106 | 106 | $340.44 | $158.95 |
|
83036
Hemoglobin a1c level
|
77 | 64 | $26.64 | $9.52 |
|
80053
Blood test, comprehensive group of blood chemicals
|
76 | 58 | $30.00 | $10.35 |
|
36415
Insertion of needle into vein for collection of blood sample
|
73 | 62 | $5.00 | $4.90 |
|
84443
Blood test, thyroid stimulating hormone (tsh)
|
67 | 57 | $33.20 | $16.46 |
|
84439
Thyroxine (thyroid chemical), free
|
52 | 46 | $20.04 | $8.84 |
|
82962
Blood glucose (sugar) test performed by hand-held instrument
|
46 | 31 | $6.56 | $3.21 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
46 | 46 | $449.28 | $211.15 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
40 | 34 | $19.18 | $7.61 |
|
80061
Blood test, lipids (cholesterol and triglycerides)
|
36 | 29 | $30.00 | $13.12 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
36 | 36 | $228.06 | $106.33 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
35 | 30 | $368.28 | $172.58 |
|
82043
Urine microalbumin (protein) level
|
23 | 22 | $11.56 | $5.66 |
|
82570
Creatinine level to test for kidney function or muscle injury
|
22 | 21 | $11.50 | $5.08 |
|
76536
Ultrasound scan of head and neck soft tissue
|
21 | 21 | $243.08 | $103.31 |
|
84481
Thyroid hormone, t3 measurement, free
|
19 | 18 | $33.88 | $16.60 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
15 | 13 | $32.24 | $15.75 |
|
83970
Parathormone (parathyroid hormone) level
|
14 | 13 | $91.72 | $40.45 |
|
82306
Vitamin d-3 level
|
13 | 13 | $65.78 | $29.01 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Mounjaro | Tirzepatide | 170 | 5,328 | $192,461.40 | 32 |
| Ozempic | Semaglutide | 163 | 8,610 | $277,421.29 | 51 |
| Levothyroxine Sodium | Levothyroxine Sodium | 116 | 10,011 | $1,177.88 | 43 |
| Jardiance | Empagliflozin | 61 | 3,977 | $76,484.49 | 20 |
| Tresiba Flextouch U-100 | Insulin Degludec | 59 | 4,433 | $47,269.67 | 23 |
| Synthroid | Levothyroxine Sodium | 57 | 4,650 | $6,159.98 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 50 | 3,730 | $509.25 | 18 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 49 | 2,625 | $54,483.53 | 11 |
| Metformin Hcl Er | Metformin Hcl | 47 | 3,940 | $450.54 | 18 |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 47 | 3,485 | $65,547.84 | 15 |
| Unithroid | Levothyroxine Sodium | 43 | 3,375 | $2,543.89 | 18 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 43 | 3,560 | $6,091.76 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 41 | 2,807 | $6,795.63 | 13 |
| Trulicity | Dulaglutide | 37 | 1,412 | $47,373.39 | — |
| Liothyronine Sodium | Liothyronine Sodium | 36 | 2,880 | $1,175.69 | 17 |
| Metformin Hcl | Metformin Hcl | 35 | 3,050 | $274.41 | 15 |
| Gabapentin | Gabapentin | 28 | 1,675 | $521.28 | — |
| Farxiga | Dapagliflozin Propanediol | 28 | 1,731 | $32,244.34 | — |
| V-Go 20 | Sub-Q Insulin Device, 20 Unit | 26 | 960 | $16,488.38 | — |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 26 | 1,852 | $6,920.81 | 11 |
| Glimepiride | Glimepiride | 25 | 1,410 | $312.93 | — |
| Prednisone | Prednisone | 24 | 1,269 | $297.54 | — |
| Humalog | Insulin Lispro | 24 | 2,219 | $10,133.52 | — |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | 1,953 | $7,502.01 | 15 |
| Tresiba Flextouch U-200 | Insulin Degludec | 24 | 1,930 | $34,359.48 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-09-04NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
NUCC Taxonomy Code: 207RE0101X
An internist who concentrates on disorders of the internal (endocrine) glands such as the thyroid and adrenal glands. This specialist also deals with disorders such as diabetes, metabolic and nutritional disorders, obesity, pituitary diseases and menstrual and sexual problems.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - ENDOCRINOLOGY
I20180524002618
TX
0446448468
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Premier Independent Physicians Group Inc
931 State Hwy 121, Allen, TX 750131182
Phone: 9727227860
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Advanced Practice Nurse
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Internal Medicine (license number reported to NPPES: TX R2233)
Registered at 931 STATE HIGHWAY 121 APT 2100, ALLEN, TX 750131182 (Tel: 9727227860)
Registered at 1512 TEASLEY LN, DENTON, TX 762057282 (Tel: 9405665010)
Internal Medicine (license number reported to NPPES: TX R2233)
NPI status registered as active in NPPES database
Registered at 100 RETREAT AVE, SUITE 400, HARTFORD, CT 061062528 (Tel: 8605471278)
Registered at 2110 SILAS DEANE HWY, ROCKY HILL, CT 060672313 (Tel: 8602583470)
Recorded as SAMEERA TALLAPUREDDY, MD
Internal Medicine (license number reported to NPPES: CT 048964)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Allen
- Dr. Mark Jennings, MD
- Dr. Luke Ouyang, MD
- Dr. Ali Bahrani, MD
- Dr. Krista Volberding, DO
- Dr. William Beaujon, MD
- Dr. Nadia Siddiqi, DO
Mailing Address
1512 Teasley Ln
Denton, TX 762057282
Phone: 9405665010